A Multi-centre, Open Label Extension Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Perampanel (E2007) as an Adjunctive Therapy in Levodopa Treated Parkinson's Disease Subjects With Motor Fluctuations.

Trial Profile

A Multi-centre, Open Label Extension Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Perampanel (E2007) as an Adjunctive Therapy in Levodopa Treated Parkinson's Disease Subjects With Motor Fluctuations.

Discontinued
Phase of Trial: Phase III

Latest Information Update: 27 Jan 2016

At a glance

  • Drugs Perampanel (Primary)
  • Indications Parkinson's disease
  • Focus Adverse reactions; Registrational; Therapeutic Use
  • Sponsors Eisai Inc
  • Most Recent Events

    • 03 Jul 2012 Additional locations added as reported by European Clinical Trials Database.
    • 02 Sep 2009 Planned end date added to 1 Apr 2008 as reported by ClinicalTrials.gov.
    • 02 Sep 2009 Status changed from not yet recruiting to discontinued as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top